<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Campbell-Salome G</submitter><funding>NHLBI NIH HHS</funding><funding>National Institutes of Health</funding><funding>National Heart Lung and Blood Institute</funding><pagination>e832-e843</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11606789</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>18(5)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Cascade testing can be highly effective in identifying individuals with familial hypercholesterolemia (FH) and help prevent atherosclerotic cardiovascular disease. The IMPACT-FH cascade testing program offered multiple optimized implementation strategies to improve FH cascade testing uptake.&lt;h4>Objective&lt;/h4>Guided by the Conceptual Model of Implementation Research, this study assessed the IMPACT-FH cascade testing program's implementation outcomes.&lt;h4>Methods&lt;/h4>Implementation outcomes were assessed qualitatively and quantitatively. Interviews were conducted with 33 IMPACT-FH program participants including 15 probands, 12 relatives, and 6 healthcare professionals (HCPs). Transcripts were analyzed using thematic analysis to investigate implementation outcomes. Descripti</pubmed_abstract><journal>Journal of clinical lipidology</journal><pubmed_title>Utilizing innovative implementation strategies for familial hypercholesterolemia: Implementation outcomes from the IMPACT-FH study.</pubmed_title><pmcid>PMC11606789</pmcid><funding_grant_id>R01HL148246</funding_grant_id><funding_grant_id>R01 HL148246</funding_grant_id><pubmed_authors>Sturm AC</pubmed_authors><pubmed_authors>McGowan MP</pubmed_authors><pubmed_authors>Walters NL</pubmed_authors><pubmed_authors>Morgan KM</pubmed_authors><pubmed_authors>Rahm AK</pubmed_authors><pubmed_authors>Tricou EP</pubmed_authors><pubmed_authors>Jones LK</pubmed_authors><pubmed_authors>Campbell-Salome G</pubmed_authors><pubmed_authors>Brangan A</pubmed_authors><pubmed_authors>Gabriel J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Utilizing innovative implementation strategies for familial hypercholesterolemia: Implementation outcomes from the IMPACT-FH study.</name><description>&lt;h4>Background&lt;/h4>Cascade testing can be highly effective in identifying individuals with familial hypercholesterolemia (FH) and help prevent atherosclerotic cardiovascular disease. The IMPACT-FH cascade testing program offered multiple optimized implementation strategies to improve FH cascade testing uptake.&lt;h4>Objective&lt;/h4>Guided by the Conceptual Model of Implementation Research, this study assessed the IMPACT-FH cascade testing program's implementation outcomes.&lt;h4>Methods&lt;/h4>Implementation outcomes were assessed qualitatively and quantitatively. Interviews were conducted with 33 IMPACT-FH program participants including 15 probands, 12 relatives, and 6 healthcare professionals (HCPs). Transcripts were analyzed using thematic analysis to investigate implementation outcomes. Descripti</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Sep-Oct</publication><modification>2026-05-29T07:04:58.448Z</modification><creation>2026-04-08T03:52:05.527Z</creation></dates><accession>S-EPMC11606789</accession><cross_references><pubmed>39278768</pubmed><doi>10.1016/j.jacl.2024.07.011</doi></cross_references></HashMap>